Since not only sepsis is associated with inflammation-induced muscle failure and increased IL-1β levels other forms of muscle atrophy might also profit from Nlrp3/IL-1β inhibition; for example, in patients with rheumatoid arthritis and inflammatory bowel disease. Here, IL1B is linked to rheumatoid arthritis.